...
首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >Intra-articular injections of hyaluronic acid (viscosupplementation) in the haemophilic knee
【24h】

Intra-articular injections of hyaluronic acid (viscosupplementation) in the haemophilic knee

机译:关节内注射血友病透明质酸(粘膜补充)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Intra-articular injections (IAIs) of hyaluronic acid, also called viscosupplementation, can be used for the treatment of radiological haemophilic arthropathy of the knee, that is when mild-to-moderate degenerative changes can be visualized on plain radiographs. This article aims to define the efficacy of IAIs of hyaluronic acid in the treatment of radiological haemophilic arthropathy of the knee. A review of recent literature on the topic has been performed. The literature seems to support the use of hyaluronic acid in the treatment of knee osteoarthritis, because it diminishes pain and improves disability, generally within 1 week and for up to 3-12 months (but especially at the 5-13-week postinjection period). There are only five reports in the literature on the efficacy of knee viscosupplementation in haemophilia, all of them with a low level of evidence. The five studies dealing with viscosupplementation in haemophilia recommend it for haemophilic arthropathy of the knee as a way of delaying the need of operative treatment when noninvasive medical therapy (relative rest, oral anti-inflammatory drugs, oral analgesics and physical therapy) has failed. The short-lived improvement afforded by viscosupplementation does not, however, seem to warrant its use in haemophilic patients given the risks and the cost involved. Further trials are required to ascertain whether viscosupplementation should be indicated in painful radiological haemophilic arthropathy of the knee.
机译:透明质酸的关节腔内注射(IAIs),也称为粘膜补充,可用于治疗膝部放射性血友病性关节炎,即在平片上可以看到轻度至中度的变性变化。本文旨在定义透明质酸IAI在治疗膝部放射性血友病性关节炎中的功效。已经对该主题的最新文献进行了回顾。文献似乎支持使用透明质酸治疗膝盖骨关节炎,因为它可减轻疼痛并改善残疾,通常在1周内长达3-12个月(但尤其是在注射后5-13周) 。文献中仅有五篇关于膝关节黏膜补充在血友病中的疗效的报道,所有这些文献的证据水平都很低。涉及血友病的粘液补充的五项研究建议将其用于膝盖的血友病性关节炎,以此作为在无创药物治疗(相对休息,口服消炎药,口服止痛药和物理疗法)失败后延迟进行手术治疗的一种方式。然而,鉴于所涉及的风险和成本,通过粘液补充提供的短暂改善似乎不值得在血友病患者中使用。需要进一步的试验以确定在疼痛的膝关节放射性血友病性关节病中是否应使用黏膜补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号